NUVA - NuVasive - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

NUVA is currently covered by 14 analysts with an average potential upside of $8.7 (15.95%) from yesterday's end of day stock price of $39.75. NuVasive activity chart has currently 201 price targets and 197 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 59.48% with an average time for these price targets to be met of 129.04 days.

Highest price target for NUVA is $56, Lowest price target is $37, average price target is $46.5.

Most recent stock forecast was given by JONATHAN DEMCHICK from MORGAN STANLEY on 04-Aug-2023. First documented stock forecast 21-Jun-2012.

Currently, out of the existing stock ratings of NUVA - 20 which are a Buy (55.56%), 16 which are a Hold (44.44%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

45

$5.25 (13.21%)

40

4 months 4 days ago

3/7 (42.86%)

$4.73 (10.50%)

65

Buy

58

$18.25 (45.91%)

56

4 months 4 days ago

2/15 (13.33%)

$15 (26.80%)

136

Hold

45

$5.25 (13.21%)

54

4 months 5 days ago

4/10 (40%)

$11.48 (22.65%)

65

Hold

45

$5.25 (13.21%)

45

4 months 5 days ago

0/3 (0%)

$2.89 (6.53%)

Hold

51

$11.25 (28.30%)

48

4 months 19 days ago

12/18 (66.67%)

$11.8 (22.92%)

301

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NUVA (NuVasive) average time for price targets to be met?

On average it took 129.04 days on average for the stock forecasts to be realized with a an average price target met ratio 59.48

Which analyst has the current highest performing score on NUVA (NuVasive) with a proven track record?

DAVID SAXON

Which analyst has the most public recommendations on NUVA (NuVasive)?

David Saxon works at NEEDHAM and has 0 price targets and 0 ratings on NUVA

Which analyst is the currently most bullish on NUVA (NuVasive)?

Craig Bijou with highest potential upside - $45.25

Which analyst is the currently most reserved on NUVA (NuVasive)?

Mike Matson with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart